📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Naurex

1.1 - Company Overview

Naurex Logo

Naurex

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage therapeutics for depression and other CNS disorders, based on a novel mechanism to modulate the N-methyl-D-aspartic acid receptor (NMDAR); developing novel chemical drug classes called glycine-site functional partial agonists (GFPAs).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Naurex

Xanodyne Logo

Xanodyne

HQ: United States Website
  • Description: Provider of integrated specialty pharmaceutical products, developing and commercializing offerings in women's healthcare and pain management in the United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xanodyne company profile →
Indivior Logo

Indivior

HQ: United States Website
  • Description: Provider of specialty pharmaceuticals focused on developing medicines for opioid use disorder (OUD). The global company works to help change patients' lives by advancing evidence-based OUD treatment and increasing access worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Indivior company profile →
Iama Therapeutics Logo

Iama Therapeutics

HQ: Italy Website
  • Description: Provider of novel neuroscience therapeutics for pediatric brain disorders, advancing drug discovery to address unmet needs; lead candidate IAMA-6 is an orally administered small molecule targeting NKCC1-associated neuronal hyperexcitability, currently in Phase 1 clinical trials for autism and epilepsy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iama Therapeutics company profile →
Eleusian Biosciences Logo

Eleusian Biosciences

HQ: Canada Website
  • Description: Provider of therapeutics in development for multiple pathological psychological diseases, based on psilocybin plus N-acetylcysteine (NAC) compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eleusian Biosciences company profile →
Zynex Medical Logo

Zynex Medical

HQ: United States Website
  • Description: Provider of medical devices of its own design, engineered, manufactured, marketed, and sold by Zynex through three subsidiaries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zynex Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Naurex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Naurex

2.2 - Growth funds investing in similar companies to Naurex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Naurex

4.2 - Public trading comparable groups for Naurex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Naurex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Naurex

What does Naurex do?

Naurex is a provider of clinical-stage therapeutics for depression and other CNS disorders, based on a novel mechanism to modulate the N-methyl-D-aspartic acid receptor (NMDAR); developing novel chemical drug classes called glycine-site functional partial agonists (GFPAs).

Who are Naurex's competitors?

Naurex's competitors and similar companies include Xanodyne, Indivior, Iama Therapeutics, Eleusian Biosciences, and Zynex Medical.

Where is Naurex headquartered?

Naurex is headquartered in United States.

How many employees does Naurex have?

Naurex has 1,000 employees 🔒.

When was Naurex founded?

Naurex was founded in 2010 🔒.

What sector and industry vertical is Naurex in?

Naurex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Naurex

Who are the top strategic acquirers in Naurex's sector and industry

Top strategic M&A buyers and acquirers in Naurex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Naurex?

Top strategic M&A buyers groups and sectors for Naurex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Naurex's sector and industry vertical

Which are the top PE firms investing in Naurex's sector and industry vertical?

Top PE firms investing in Naurex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Naurex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Naurex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Naurex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Naurex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Naurex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Naurex?

The key public trading comparables and valuation benchmarks for Naurex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Naurex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Naurex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Naurex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Naurex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Naurex's' sector and industry vertical?

Access recent funding rounds and capital raises in Naurex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Naurex

Launch login modal Launch register modal